Tyler Sloan earned his B.Sc. and Ph.D. from McGill University. Instead of doing a traditional postdoctoral fellowship, he founded Quorumetrix, a scientific data analysis and visualization studio based in Montréal. He specializes in data visualization and 3D animation, presenting primary research data in an attractive and engaging way while maintaining robust scientific accuracy. His award-winning visualizations have been featured in prominent academic journals and conferences. Sloan embraces a generalist approach and loves the challenge of exploring new data types, and he is particularly passionate about full-dome visualization.
Tyler Sloan
Data scientist
Quorumetrix
From this contributor
To develop better nervous-system visualizations, we need to think BIG
With a full mouse connectome on the horizon, neuroscience needs to overcome its legacy of minimalism and embrace the contemporary challenge of representing whole-nervous-system connectivity.
To develop better nervous-system visualizations, we need to think BIG
By
Tyler Sloan
8 July 2024 | 8 min read
Explore more from The Transmitter
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
By
Ashley Juavinett
30 March 2026 | 8 min read
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
By
Dalmeet Singh Chawla
27 March 2026 | 5 min read
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
By
Claudia López Lloreda
26 March 2026 | 4 min read